mRNA-based monkeypox virus vaccine prevents disease in non-human primates.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 38490180.
- Also identified by DOI 10.1016/j.cell.2024.02.011.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The mpox outbreak in 2022 launched a vaccination campaign employing an existing vaccine with moderate protection, highlighting the lack of scalable Orthopoxvirus vaccines with optimal protection. In this issue of Cell, Zuiani et al. report pre-clinical findings of an mRNA-based mpox vaccine, paving the way for Phase I/II clinical trials.
Medical subject headings
- mRNA Vaccines
- Smallpox Vaccine
- Viral Vaccines